new medicine

New human medicines

  1. Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Asthma, Date of authorisation: 19/09/2022, Status: Authorised

    Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Asthma, Date of authorisation: 19/09/2022, Status: Authorised

  2. Summary of opinion: Enjaymo,sutimlimab, 15/09/2022, Positive

    Summary of opinion: Enjaymo,sutimlimab, 15/09/2022, Positive

  3. Summary of opinion: Melatonin Neurim,melatonin, 15/09/2022, Positive

    Summary of opinion: Melatonin Neurim,melatonin, 15/09/2022, Positive

  4. Summary of opinion: Pyrukynd,mitapivat, 15/09/2022, Positive

    Summary of opinion: Pyrukynd,mitapivat, 15/09/2022, Positive

  5. Summary of opinion: Adtralza,tralokinumab, 15/09/2022, Positive

    Summary of opinion: Adtralza,tralokinumab, 15/09/2022, Positive